Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales
6. Analysed the core values, mission and vision statement, resources and capabilities,
stakeholder analysis and engagement, organisation culture of Pfizer. This project report explains the current status of Pfizer in Ireland and future business strategy for business growth. By analyzing PESTEL and SWOT, the report provides a recommendation for the future business strategy for Pfizer to reduce weaknesses in the market.
Strategic Management Case of Pfizer. From text book by David, Fred R. "Strategic Management Concepts & Cases",13 th Ed. Assignment on Strategic Management Class in Universitas Tarumanegara Post Graduate class.
Indian pharmaceutical industry organisational structure & strategiesPankaj Gaurav
Strategic Implementation & control Project Report on organizational structure and strategies adopted by prominent players in Indian pharmaceutical industry
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
List of pharma companies in Mohali | PharmaaddaAditiMehra14
Mentioned above is the List Of Pharma Companies in Mohali. Invest in these pharma franchise companies for growth. For More details visit the blog. http://www.pharmaadda.in/list-of-pharma-companies-in-mohali
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales
6. Analysed the core values, mission and vision statement, resources and capabilities,
stakeholder analysis and engagement, organisation culture of Pfizer. This project report explains the current status of Pfizer in Ireland and future business strategy for business growth. By analyzing PESTEL and SWOT, the report provides a recommendation for the future business strategy for Pfizer to reduce weaknesses in the market.
Strategic Management Case of Pfizer. From text book by David, Fred R. "Strategic Management Concepts & Cases",13 th Ed. Assignment on Strategic Management Class in Universitas Tarumanegara Post Graduate class.
Indian pharmaceutical industry organisational structure & strategiesPankaj Gaurav
Strategic Implementation & control Project Report on organizational structure and strategies adopted by prominent players in Indian pharmaceutical industry
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
List of pharma companies in Mohali | PharmaaddaAditiMehra14
Mentioned above is the List Of Pharma Companies in Mohali. Invest in these pharma franchise companies for growth. For More details visit the blog. http://www.pharmaadda.in/list-of-pharma-companies-in-mohali
SPH Sine Pharmaceutical Laboratories Adds Precision To The Recipe
Made in China 2025 inspires manufacturers to adopt leading-edge technology that reduces reliance on manual processes and their potential for error. SPH Sine Pharmaceutical Laboratories selected PharmaSuite MES from Rockwell Automation to standardize and track their microbe building and solid preparation processes. The system is poised to reduce human error, meet new regulatory requirement and boost productivity.
CAREER OVERVIEW
I am a pharmaceutical management professional with experience of 8 years in the pharmaceutical sales and marketing, 1.5 years in administrative corporate management, 5 years in the research and development innovation project management, 1.5 years as a Medical Director, and one year as a CRO Managing Director. I have worked in multinational and Egyptian pharmaceutical companies with a proven track record of developing new business and motivating cross-functional teams to consistently achieve action plans. I've completed a Doctorate of Business Administration with distinction and looking for interesting opportunities in the pharmaceutical research field in which my skills set can add value to an organization with the goal of benefiting humanity. I am willing to relocate.
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will Be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India. Please find the detailed agenda for the same with this email.
FMD:- + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
This ppt was made by my friend Svenia & I. It is a summary of the journal on 'Influence of mineral and vitamin supplements on pregnancy outcome'.
Hope it helps.
This is a summary of the journal : 'Is there more to learn about functional vitamin D metabolism?' presented by my friend Svenia and me. Hope it helps.
This presentation is on ocean acidification, it covers
(1) a background on ocean acidification,
(2) the chemistry between carbon dioxide & the ocean
(3) Impact of Ocean acidification on biological processes and the ecosystems.
(4) and finally some mitigation measures
I hope this ppt be useful & helpful to people working on this topic :)
Enjoy
This is a portfolio on 5 different plants with pharmacological properties prepared by my colleague Svenia and Myself. It covers some important aspects such as background, uses and preparations etc. Hope it helps.
Gap junctional intercellular communication in cancer chemopreventionNabiilah Naraino Majie
This powerpoint presentation gives an overview of how gap junctions are involved in cancer. And how it can be upregulated by the action of phytochemicals in the process of cancer chemoprevention. I have used a scientific journal to eleborate on the mechanism. I hope it helps.
This ppt explains the basics of mass spectrometry and in application in pharmacognosy. Hope this helps you guys. Like, comment and save. If you hav problem downloading, send your email address; i'll post it for you by mail :)
Enjoy the presentation.
This presentation is on the bioassay of heparin which helps to know the potency of new heparin drug or heparin conc in individual suffering from heparin resistance diseases.
This was made by my friend Naailah and me. Hope it helps.
This prsentation explains the use of biomarker with reference to an article: Accelerating Drug Develeopment using Biomarkers-Sitagliptin.
It was presented my my 2 friends and me. Hope it helps you guys.
A presentation on Paul Ehrlich developed modern chemotherapy. This was my ppt for the module pharmaceutics 6. It i based on Anti microbial chemo; hope it help others doing relating things.
This was my pharmaceutics presentation for mixing. Provides definitions, mechanism, types of mixers etc.
P.S: I am not the sole presenter. Ideas are from my two other colleagues as well.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
2. Table of Content
• Introduction
• History
• Strategy
• Key facts and figures
• Sanofi Management System (SMS)
• Conclusion
3. Introduction
• Sanofi is a French multinational pharmaceutical company headquartered in Paris,
France
• As from 2014, it is known as the world's forth-largest pharmaceutical company by
prescription sales.
• Logo: Motto:
• Sanofi engages in the
– research and development,
– manufacturing and marketing of pharmaceutical drugs principally in the prescription market,
– but the firm also develops over-the-counter medication.
4. • The company covers seven major therapeutic areas:
– Cardiovascular,
– central nervous system,
– diabetes,
– internal medicine,
– oncology,
– thrombosis
– and vaccines (it is the world's largest producer of the latter through
its subsidiary Sanofi Pasteur)
Introduction
5. • This company is a complex of individual companies that
have been merged together.
• Back in 1999, Sanofi was the second largest
pharmaceutical in France and number seven in Europe
according to the 1999 annual report.
History
Aventis
(1999)
Sanofi
(1973)-
Synthelabo
(1970)
[1999]
Sanofi-
Aventis
(2004)
Sanofi
(2011)
6. • The merger of pharmaceuticals is quite common in the sector.
• It came as a response to new competition and a change in the
healthcare sector where margins are cut.
• The company experienced internal and external challenges inherent in
this complex environment due to the introduction of generic
competitors.
• Therefore, the company has changed its government structure. The
long-prepared separation of the office of Chairman of the Board of
Directors and Chief Executive Officer assured continuity in the
strategy, dynamism and culture of sanofi-aventis
History
7. • The Company is managed by a Board of Directors composed of 14
members, 10 of whom are independent (a Director who has no relation
whatsoever with the company, its group or its management which may
impede his freedom of decision.)
• Members of our Board of Directors are appointed for a maximum term of four
years; reappointment of Directors is on a rotation basis
• In this way the company is following the global corporate governance "best-
practice”.
• The company has a strong and increasing presence in the BRIC- countries
(Brasil, Russia, India and China), but about 70% of the sales is achieved in
Europe and the US.
History
17. Sanofi Management System
(SMS)
SMS is a foundation for
industrial excellence, it uses a
strategic vision and ambition
to make Sanofi the gold-
standard for pharmaceutical
industry
18. Sanofi Management System
(SMS)
• Present in many countries to ensure patients and customers satisfaction
• Employs people to assist in proper health distribution
• Provides a large range of expertise and know-how for development of new
drugs from production to distribution
• Work towards achieving a gold standard in the pharmaceutical industry
• Build fundamentals with no compromise
24. Conclusion
• Acting ethically and responsibly enables Sanofi to go beyond what is required
of a company, which means employees working to protect and promote access
to healthcare for the greatest number.
• Corporate Social Responsibility also means supporting the local communities
in the countries where we operate while also contributing to global health
through specific Research & Development programs and private/public
collaboration.
• By considering the method Sanofi follows, there are great chances for it to
climb the ladder to be part of the best three pharmaceutical industries worldwide.
25. • Research & Development, Available at:
http://en.sanofi.com/Images/15406_RD_Portfolio_Phase_II-I_2015-07-30.pdf,
http://en.sanofi.com/Images/15395_RD_Portfolio_Pipeline_2015-07-30.pdf and
http://en.sanofi.com/Images/15404_RD_Portfolio_Phase_III_2015-07-30.pdf
• Sanofi Pipeline, Available at: http://www.sanofi.co.uk/l/gb/en/layout.jsp?scat=E096581E-
095C-45A7-BA82-AD5417CFBB83
• Sanofi Website at http://www.sanofi.co.uk/l/gb/en/index.jsp
• Sanofi at a glance, 2015, Available at: www.lehub.sanofi.com/en
• Sanofi History, Available at: https://en.wikipedia.org/wiki/Sanofi#History,
http://en.sanofi.com/our_company/history/history.aspx and
http://ezinearticles.com/?Company-Profiles---Sanofi-Aventis&id=1173003
• Sanofi Slogan, Available at: http://www.textart.ru/advertising/slogans/health/pharmaceutical-
company-slogans.html
• CSR Sanofi, 2014 report and mid 2015 report
References
Editor's Notes
Tritace® (ramipril)
Epilim® (sodium valproate) & Stilnox® (zolpidem)
Lantus® (insulin glargine), a long-acting human insulin analog, market leader for branded insulins (IMS source). Lantus® is available is more than 120 countries worldwide.
Toujeo® (Insulin glargine).
Apidra® (insulin glulisine) a rapid-acting human insulin analog.
Insuman®, a range of rapid- and intermediate-acting human insulins.
Lyxumia® (lixisenatide) is a once-daily prandial GLP-1 receptor agonist.
Amaryl®/Amarel® (glimepiride), a sulfonylurea-class hypoglycemic.
Afrezza® (insulin human) is a rapid-acting, inhaled insulin. Only available in the United-States.
4.
First of all, Aventis was formed in 1999 by the merger of Rhône-Poulenc and the German company Hoechst AG in France
In 2004 this new company merged with Sanofi that itself had completed a merger with Synthelabo.
Since 2004 the company name is Sanofi-Aventis.
At the beginning of February 2015, the R&D pipeline contained 43 projects (excluding Life Cycle Management) and vaccine candidates in clinical development of which 14 are in Phase III or have been submitted to the regulatory authorities for approval.